Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | (+-)-Quinacrine | HCID 237 | — |
| Reactant | Putrescine | HCID 1045 | — |
| Reactant | Sodium Hydroxide | HCID 14798 | — |
| Reactant | 3,9-Dichloro-7-methoxyacridine | HCID 66577 | — |
| Solvent | Phenol | HCID 996 | — |
| Product | 9-Aminoacridine | HCID 7019 | — |
Reaction Steps
A diamine side chain is first synthesized in a manner analogous to the side chain of quinacrine. Specifically, mono-phthaloyl protected 1,4-diaminobutane (27) is reacted with 6,9-dichloro-2-methoxyacridine (28) in phenol (J. Am. Chem. Soc. 66:1921-1924, 1944). The reaction mixture is then poured into an excess of 2 N NaOH and extracted with ether. The ether extract is washed with 1 M NaHCO3, then H2O, and dried over MgSO4. The crude product is recrystallized from H2O-alcohol. The phthaloyl protecting group is removed using anhydrous hydrazine in MeOH (Bioconjugate Chem. 2:435-440, 1991) to yield the aminoacridine, (29). Aminoacridine (29) is then conjugated with vitamin B12 monocarboxylic acid (2, 3, 4) to yield a cyanocobalamin-acridine conjugate (30).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06083926 |
|---|
| Source dataset | uspto-grants-2000_07 |
|---|
| ORD ID | ord-4d157082256a43be92f5ac3fbf67e205 |
|---|
| Source note | uspto-grants-2000_07 |
|---|